CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Anuh Pharma Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Anuh Pharma Ltd
E - 17/3 & 17/4
M.I.D.C., Tarapur,Boisar
Phone: +91 2266227575p:+91 2266227575 MUMBAI, 400018  India Ticker: 506260506260
Business Summary
Anuh Pharma Limited is an India-based company, which is engaged in the business of manufacturing and selling of bulk drugs and chemicals. The Company's products include active pharmaceutical ingredients and corticosteroids. Its active pharmaceutical ingredients include macrolides, anti-tb, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, intermediates and under development. Its macrolides products include erythromycin, erythromycin ethyl succinate, erythromycin stearate, erythromycin estolate, erythromycin propionate and erythromycin phosphate. Its anti-malarial sulfadoxine and pyrimethamine. The Company's anti-hypertension products include losartan potassium, telmisartan and atorvastatin calcium. The Company's corticosteroids include anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, antihistamines and under development. Its anti-inflammatory products include dexamethasone na phosphate, mometasone furoate and clobetasol butyrate.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2899 Chemicals and chemical preparations, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Arun L.Todarwal 66 4/1/2024 10/24/2008
Non-Executive Vice Chairman of the Board Bipin N.Shah 1/8/2021 1/8/2021
Chief Financial Officer DarshanRampariya 3/31/2022 3/31/2022
6 additional Officers and Directors records available in full report.

Business Names
Business Name
506260
Anuh Pharma Ltd

General Information
Number of Employees: 175 (As of 3/31/2024)
Outstanding Shares: 50,112,000 (As of 9/30/2024)
Shareholders: 22,677
Stock Exchange: BOM
Fax Number: +91 2266227600


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024